glp-1 and surgery risk medications safe to continue before in patients with diabetes obesity GLP-1 RAs may reduce pseudoarthrosis
Description
We will be with you every step of the way
Separately, orforglipron (Foundayo) - a daily oral GLP-1 receptor agonist pill from Eli Lilly - also received FDA approval in May 2026 for weight management
ArticlePubMed 65
Pharmacological treatment of hyperglycemia in type 2 diabetes
These side effects are typically mild and manageable
The key is a balanced approach to treatment, which includes consistent monitoring and adjustments based on the patients progress
